Elizabeth Brém, MD, HS Clinical Assistant, Professor Chao Comprehensive Cancer Center discusses the Future of Relapse Refractory Treatment in Hodgkins Lymphoma at the MOASC Spotlight on ASH meeting 2017.
The Future of Relapse Refractory Treatment in Hodgkin Lymphoma
